Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Function of mutant and wild-type plexinb1 in prostate cancer cells.

Damola A, Legendre A, Ball S, Masters JR, Williamson M.

Prostate. 2013 Sep;73(12):1326-35. doi: 10.1002/pros.22678. Epub 2013 Jun 15.

2.

Effect of cancer-associated mutations in the PlexinB1 gene.

Zhou C, Wong OG, Masters JR, Williamson M.

Mol Cancer. 2012 Mar 9;11:11. doi: 10.1186/1476-4598-11-11.

3.

Semaphorin 4D, a lymphocyte semaphorin, enhances tumor cell motility through binding its receptor, plexinB1, in pancreatic cancer.

Kato S, Kubota K, Shimamura T, Shinohara Y, Kobayashi N, Watanabe S, Yoneda M, Inamori M, Nakamura F, Ishiguro H, Nakaigawa N, Nagashima Y, Taguri M, Kubota Y, Goshima Y, Morita S, Endo I, Maeda S, Nakajima A, Nakagama H.

Cancer Sci. 2011 Nov;102(11):2029-37. doi: 10.1111/j.1349-7006.2011.02053.x. Epub 2011 Sep 13.

4.

Plexin-B1 plays a redundant role during mouse development and in tumour angiogenesis.

Fazzari P, Penachioni J, Gianola S, Rossi F, Eickholt BJ, Maina F, Alexopoulou L, Sottile A, Comoglio PM, Flavell RA, Tamagnone L.

BMC Dev Biol. 2007 May 22;7:55.

5.

Plexin-B1 mutations in prostate cancer.

Wong OG, Nitkunan T, Oinuma I, Zhou C, Blanc V, Brown RS, Bott SR, Nariculam J, Box G, Munson P, Constantinou J, Feneley MR, Klocker H, Eccles SA, Negishi M, Freeman A, Masters JR, Williamson M.

Proc Natl Acad Sci U S A. 2007 Nov 27;104(48):19040-5. Epub 2007 Nov 16.

6.

Semaphorin-plexin signalling genes associated with human breast tumourigenesis.

Gabrovska PN, Smith RA, Tiang T, Weinstein SR, Haupt LM, Griffiths LR.

Gene. 2011 Dec 10;489(2):63-9. doi: 10.1016/j.gene.2011.08.024. Epub 2011 Sep 2.

PMID:
21925246
7.

Plexin-B1 signalling promotes androgen receptor translocation to the nucleus.

Williamson M, de Winter P, Masters JR.

Oncogene. 2016 Feb 25;35(8):1066-72. doi: 10.1038/onc.2015.160. Epub 2015 May 18.

PMID:
25982277
8.

Semaphorin 4D induces vaginal epithelial cell apoptosis to control mouse postnatal vaginal tissue remodeling.

Ito T, Bai T, Tanaka T, Yoshida K, Ueyama T, Miyajima M, Negishi T, Kawasaki T, Takamatsu H, Kikutani H, Kumanogoh A, Yukawa K.

Mol Med Rep. 2015 Feb;11(2):829-36. doi: 10.3892/mmr.2014.2773. Epub 2014 Oct 27.

9.

CXCL12-CXCR4 interactions modulate prostate cancer cell migration, metalloproteinase expression and invasion.

Singh S, Singh UP, Grizzle WE, Lillard JW Jr.

Lab Invest. 2004 Dec;84(12):1666-76.

10.

Plexin-B2, but not Plexin-B1, critically modulates neuronal migration and patterning of the developing nervous system in vivo.

Deng S, Hirschberg A, Worzfeld T, Penachioni JY, Korostylev A, Swiercz JM, Vodrazka P, Mauti O, Stoeckli ET, Tamagnone L, Offermanns S, Kuner R.

J Neurosci. 2007 Jun 6;27(23):6333-47.

11.

Sema4D, the ligand for Plexin B1, suppresses c-Met activation and migration and promotes melanocyte survival and growth.

Soong J, Chen Y, Shustef EM, Scott GA.

J Invest Dermatol. 2012 Apr;132(4):1230-8. doi: 10.1038/jid.2011.414. Epub 2011 Dec 22.

12.

The Vav3 oncogene enhances the malignant potential of prostate cancer cells under chronic hypoxia.

Hirai K, Nomura T, Yamasaki M, Inoue T, Narimatsu T, Chisato Nakada PD, Yoshiyuki Tsukamoto PD, Matsuura K, Sato F, Moriyama M, Mimata H.

Urol Oncol. 2014 Feb;32(2):101-9. doi: 10.1016/j.urolonc.2012.09.005. Epub 2013 Feb 9.

PMID:
23403204
13.

Semaphorin 4D regulates gonadotropin hormone-releasing hormone-1 neuronal migration through PlexinB1-Met complex.

Giacobini P, Messina A, Morello F, Ferraris N, Corso S, Penachioni J, Giordano S, Tamagnone L, Fasolo A.

J Cell Biol. 2008 Nov 3;183(3):555-66. doi: 10.1083/jcb.200806160.

14.

Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.

Weiss-Messer E, Merom O, Adi A, Karry R, Bidosee M, Ber R, Kaploun A, Stein A, Barkey RJ.

Mol Cell Endocrinol. 2004 May 31;220(1-2):109-23.

PMID:
15196705
16.

Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models.

Denmeade SR, Sokoll LJ, Dalrymple S, Rosen DM, Gady AM, Bruzek D, Ricklis RM, Isaacs JT.

Prostate. 2003 Mar 1;54(4):249-57.

PMID:
12539223
17.
18.

Survivin mediates resistance to antiandrogen therapy in prostate cancer.

Zhang M, Latham DE, Delaney MA, Chakravarti A.

Oncogene. 2005 Apr 7;24(15):2474-82.

PMID:
15735703
19.

Suppression of prostate tumor cell growth in vivo by WT1, the Wilms' tumor suppressor gene.

Fraizer G, Leahy R, Priyadarshini S, Graham K, Delacerda J, Diaz M.

Int J Oncol. 2004 Mar;24(3):461-71.

PMID:
14767530
20.

Promotion of angiogenesis by ps20 in the differential reactive stroma prostate cancer xenograft model.

McAlhany SJ, Ressler SJ, Larsen M, Tuxhorn JA, Yang F, Dang TD, Rowley DR.

Cancer Res. 2003 Sep 15;63(18):5859-65.

Supplemental Content

Support Center